5-ARIs in prevention of prostate cancer — an update

The recent publication of an article on trends in the prescription of finasteride has re-stimulated the debate on the use of 5α-reductase inhibitors (5-ARIs) like finasteride and dutasteride in the prevention of prostate cancer. … READ MORE …

5-ARIs in treatment of prostate cancer: a new review

In August this year, Vis and Schröder published the first of two summary reviews on the key targets of hormonal treatment of prostate cancer. The second of these two key reviews has now appeared in the November issue of BJU International. … READ MORE …

The daily news update: Wednesday, March 11, 2009

Reports today deal with:

  • 5α-Reductase inhibitors and other agents in prevention of prostate cancer
  • Expansion of patient eligibility for an Ablatherm HIFU trial in the USA
  • Osteoprotegerin in development and progression of bone metastases
  • Chemo-immunotherapy for treatment of metastatic disease … READ MORE …